LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) updated its FY23 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.25-1.35 for the period, compared to the consensus earnings per share estimate of $1.19. The company issued revenue guidance of $193.0-197.8 million, compared to the consensus revenue estimate of $189.59 million. LeMaitre Vascular […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) issued an update on its third quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.28-0.33 for the period, compared to the consensus estimate of $0.27. The company issued revenue guidance of $46.5-48.9 million, compared to the consensus revenue estimate of $45.86 […]
Jefferies Financial Group downgraded shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a report published on Thursday morning, Marketbeat Ratings reports. The brokerage currently has $67.00 target price on the medical instruments supplier’s stock, up from their prior target price of $63.00. Several other research firms […]
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 Earnings Guidance themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.25-1.35 for the period, compared to the consensus estimate of $1.19. The company issued revenue guidance of $193.0-197.8 million, compared to the consensus revenue estimate of $189.59 million. […]